Home BioPhausia AB

BioPhausia AB

acquired
-
A Swedish specialty pharmaceutical company
Basic
Enterprise Profile

Basic Information

BioPhausia is a Swedish specialty pharmaceutical company. BioPhausia focuses on the marketing and sales of its own products, licensed products, and parallel imported products. The portfolio includes strong brands such as Novalucol, Citodon, and Mollipect.
BioPhausia AB
--
101~500 people
January 01, 1994
carl.lindgren@karopharma.se

Enterprise Profile

Application Scenarios
Biologics